ID
33807
Beschrijving
The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01083251
Link
https://clinicaltrials.gov/show/NCT01083251
Trefwoorden
Versies (1)
- 28-12-18 28-12-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
28 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis B Virus NCT01083251
Eligibility Hepatitis B Virus NCT01083251
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Decompensated liver disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C4075847
Beschrijving
Antiviral Therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0280274
Beschrijving
Coinfection Viral | HCV coinfection | Hepatitis Delta Virus Coinfection | HIV coinfection
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0275524
- UMLS CUI [1,2]
- C0521026
- UMLS CUI [2]
- C1698259
- UMLS CUI [3,1]
- C0011220
- UMLS CUI [3,2]
- C0275524
- UMLS CUI [4]
- C4062778
Beschrijving
Neutropenia Pre-existing | Thrombocytopenia Pre-existing
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0027947
- UMLS CUI [1,2]
- C2347662
- UMLS CUI [2,1]
- C0040034
- UMLS CUI [2,2]
- C2347662
Similar models
Eligibility Hepatitis B Virus NCT01083251
- StudyEvent: Eligibility
C0449238 (UMLS CUI [1,2])
C0948827 (UMLS CUI [2])
C0193388 (UMLS CUI [1,2])
C0332290 (UMLS CUI [2,1])
C0524909 (UMLS CUI [2,2])
C0521026 (UMLS CUI [1,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C4062778 (UMLS CUI [4])
C2347662 (UMLS CUI [1,2])
C0040034 (UMLS CUI [2,1])
C2347662 (UMLS CUI [2,2])